StonvexLoading…
StonvexCore line items from L's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.17B | $2.89B | $2.36B | $2.09B |
Operating Income | $2.28B | $1.87B | $2.00B | $1.11B |
Net Income | $1.67B | $1.41B | $1.43B | $822.00M |
EPS (Diluted) | $7.97 | $6.41 | $6.29 | $3.38 |
Total Assets | $86.35B | $81.94B | $79.20B | $75.57B |
Total Liabilities | $66.71B | $64.01B | $62.67B | $60.37B |
Cash & Equivalents | $495.00M | $541.00M | $399.00M | $532.00M |
Free Cash Flow OCF − CapEx | $2.70B | $2.39B | $3.22B | $2.65B |
Shares Outstanding | 209.10M | 220.53M | 227.81M | 243.28M |